Hemoteq GmbH
Development and manufacturing of ultra-thin coatings for medical devices
Michael Hoffmann and Roland Horres founded Hemoteq in 1999 after they had won 30 000 DM in the “Netzwerk und Know-How” business plan contest.
Michael Hoffman, Dr., CEO
Roland Horres, SVP R&D
Adenauerstr. 15
52146 Würselen
Germany
Phone: +49-2405-455-000
Fax: +49-2405-455-012
Proprietary substances and nanocoatings are applied to a wide range of materials in order to add haemocompatible, bioactive, hydrophilic, and lubricious properties. Biomimetic coatings, nanocoating compositions, and drug-delivery systems are offered.
The company focuses on wet chemistry processes in order to ensure a durable covalent bonding of ultrathin monolayers. Custom and prototype coatings can be formulated and large-scale cleanroom manufacturing is available.
The following section contains a selection of the company’s most relevant patents. For comprehensive patent information please refer to the espacenet databases.
Related patents
- Biocompatible Coating, Method, and Use of Medical Surfaces
- Biocompatible Coating, Method, and Use of Medical Surfaces
- Compounds and Method for Coating Surfaces of Medical Devices Such as Stents in a Haemocompatible Manner
- Caspase Inhibitors as Coating Materiel for Medical Products for Inhibiting Restenosis
- Compounds and Method for Coating Surfaces in a Haemocompatible Manner
- Biocompatible, Biostable Coating of Medical Surfaces
- A Method for Coating the Net or Mesh Fabric of Surgically Used Blood Vessel Stents Has a First Thin Coating Applied to the Web Material and a Second Thicker Coating Applied to the Webs and Gaps
- All-over Coating of Vessel Stents
- Stent for Stabilizing Blood Vessels, Useful for Inhibiting Restenosis After Vascular Intervention, is Coated with Peptide Inhibitor of Caspase
- Medical Products Comprising a Haemocompatible Coating, Production and Use Thereof.
- Coating of Stents for Preventing Restenosis
- New Aminated Oligo- or Polysaccharide Derivatives Obtained from Heparin, Chitosan or Chitin, Useful for Producing Hemocompatible Coatings on Medicinal Products, Especially Stents
- Beschichtung von Stents zur Verhinderung von Restenose
- Method for Purifying Full Blood
- Medical Products Comprising a Haemocompatible Coating, Production and Use Thereof
- Biocompatible Medicinal Products, Especially Restenosis Inhibiting Stents, Having Biostable Surface Coating of Polysulfone, Preferably Providing Controlled Release of Active Agent, e.g. Antiproliferative Agent
- Biocompatible, Biostable Coating of Medical Surfaces
- Verbindungen und Verfahren zur Hemokompatiblen Beschichtung von Oberflächen
- Reduktion der Schallemission von Dünnwadigen Bauteilen in Magnetresonazgeräten
- Coating of Stents for Preventing Restenosis
- Oligopeptides as Coating Material for Medical Products
- Coating of Stents for Preventing Restenosis